van Staa, T. P., Abenhaim, L. ., & Cooper, C. . (1998). Use of cyclical etidronate and prevention of non-vertebral fractures. Br J Rheumatol.
L. Abenhaim
First name
L.
Last name
Abenhaim
Van Staa, T. ., Abenhaim, L. ., & Monette, J. . (1997). Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol.
Van Staa, T. ., Abenhaim, L. ., & Cooper, C. . (1997). Upper gastrointestinal adverse events and cyclical etidronate. Am J Med.
van Staa, T. P., Leufkens, H. ., Abenhaim, L. ., & Cooper, C. . (1998). Postmarketing surveillance of the safety of cyclic etidronate. Pharmacotherapy.
Marrie, R. A., Wolfson, C. ., Sturkenboom, M. C., Gout, O. ., Heinzlef, O. ., Roullet, E. ., & Abenhaim, L. . (2000). Multiple sclerosis and antecedent infections: a case-control study. Neurology.
van Staa, T. P., Leufkens, H. G., Abenhaim, L. ., Zhang, B. ., & Cooper, C. . (2000). Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford).
van Staa, T. P., Abenhaim, L. ., Cooper, C. ., Zhang, B. ., & Leufkens, H. G. (2000). The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/1099-1557(200009/10)9:5<359::aid-pds507>3.0.co;2-e
van Staa, T. P., Leufkens, H. G., Abenhaim, L. ., Zhang, B. ., & Cooper, C. . (2000). Use of oral corticosteroids and risk of fractures. J Bone Miner Res. http://doi.org/10.1359/jbmr.2000.15.6.993
van Staa, T. P., Leufkens, H. G., Abenhaim, L. ., Begaud, B. ., Zhang, B. ., & Cooper, C. . (2000). Use of oral corticosteroids in the United Kingdom. Qjm.
van Staa, T. P., Abenhaim, L. ., Cooper, C. ., Zhang, B. ., & Leufkens, H. G. (2001). Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol.